United Services Automobile Association’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

United Services Automobile Association’s Portfolio PHAS Stock Details PHAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-107,267	Closed	-$1.41M	–	1935
2019 Q2	$1.41M	Buy	107,267 +14,653	+16%	+$180K	﹤0.01%	1199
2019 Q1	$881K	Hold	92,614	–	–	﹤0.01%	1373
2018 Q4	$286K	Buy	+92,614	New	+$367K	﹤0.01%	1844

Other funds holding PHAS

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

United Services Automobile Association's PHAS Position: Q3 2019 in Review

United Services Automobile Association sold out of PhaseBio Pharmaceuticals, Inc. Common Stock (PHAS) in Q3 2019, closing a stake of 107,267 shares — an estimated $1.41M sold.

United Services Automobile Association first reported a position in PHAS in Q4 2018 and held it in 3 quarters. The position peaked at $1.41M in Q2 2019. 58 funds tracked by Wall St. Rank hold PHAS as of Q3 2019.

United Services Automobile Association reported no remaining PhaseBio Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
United Services Automobile Association sold 107,267 PhaseBio Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $1.41M.
United Services Automobile Association first reported a position in PhaseBio Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 3 quarters.
United Services Automobile Association's PhaseBio Pharmaceuticals, Inc. Common Stock position peaked at $1.41M in Q2 2019.
58 funds tracked by Wall St. Rank held PhaseBio Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.